Concepedia

André T. Brunetto

AT

Statistics

Publications

28

Citations

1.1K

H-Index

19

Active since

2009

Affiliations

Royal Marsden NHS Foundation Trust(Current)

Universidade Federal do Rio Grande do Sul

Institute of Cancer Research

Hospital de Clínicas de Porto Alegre

Royal Marsden Hospital

André T. Brunetto is an author at Royal Marsden NHS Foundation Trust specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2009–2021

28

Publications

28

Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies

Timothy A. Yap, David Olmos, André T. Brunetto et al. · Journal of Clinical Oncology · 2011 · 195 citations · Full text

, , +16

Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies

David Olmos, Douglas S. Barker, Rohini Sharma et al. · Clinical Cancer Research · 2011 · 168 citations · Full text

, , +16

Patient Selection for Oncology Phase I Trials: A Multi-Institutional Study of Prognostic Factors

David Olmos, Roger A’Hern, Silvia Marsoni et al. · Journal of Clinical Oncology · 2012 · 81 citations · Full text

, , +16

Gastrin-Releasing Peptide Receptor Expression in Lung Cancer

Jane Mattei, Rosane Duarte Achcar, C. Cano et al. · Archives of Pathology & Laboratory Medicine · 2013 · 67 citations · Full text

, , +17

A phase I study of MK-2206, an oral potent allosteric Akt inhibitor (Akti), in patients (pts) with advanced solid tumor (ST)

Anthony W. Tolcher, Tami Yap, Ivy Fearen et al. · Journal of Clinical Oncology · 2009 · 63 citations

, , +16

1–5 of 28